Profile data is unavailable for this security.
About the company
Lincoln Pharmaceuticals Limited is engaged in the business of manufacturing and trading pharmaceutical products, as well as undertaking contract manufacturing from pharmaceuticals companies across India and the globe. The Company’s product categories include tablets, capsules, liquid injection, cream in tubes, eye/ear drops, dry power injection, SVP injectables, dry-powder suspensions, liquid injection, and pharma products. It offers products for anti-infective, respiratory system, gynecology, cardio and CNS (central nervous system), antibacterial, dermatological infection, anti-diabetic, and anti-malaria. The Company is also engaged in building a portfolio of lifestyle and chronic segments, primarily in women’s healthcare and dermatology. The Company caters to approximately 60 countries in Europe, Latin America, Africa, Asia Pacific, Southeast Asia, and 26 states across India. The Company has two manufacturing facilities located in Mehsana and Khatraj, Gujarat.
- Revenue in INR (TTM)6.52bn
- Net income in INR878.34m
- Incorporated1995
- Employees1.85k
- LocationLincoln Pharmaceuticals LtdLINCOLN HOUSE, B/h. Satyam ComplexScience City Road, SolaAHMEDABAD 380060IndiaIND
- Phone+91 7 967778000
- Fax+91 7 930018062
- Websitehttps://www.lincolnpharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Venus Remedies Ltd | 7.00bn | 762.95m | 8.71bn | 1.30k | 11.41 | -- | 8.72 | 1.24 | 57.10 | 57.10 | 523.77 | -- | -- | -- | -- | 5,391,957.00 | -- | 6.67 | -- | 8.08 | 47.02 | 37.62 | 10.90 | 6.87 | -- | 1,849.19 | -- | -- | 7.72 | 13.81 | 59.05 | -- | 18.36 | -- |
| Wanbury Ltd | 6.58bn | 646.86m | 8.85bn | 1.38k | 13.24 | -- | 11.18 | 1.35 | 19.13 | 19.13 | 194.16 | -- | -- | -- | -- | 4,758,967.00 | -- | 8.87 | -- | 101.40 | 55.07 | 41.82 | 9.84 | 5.62 | -- | 2.97 | -- | -- | 4.15 | 10.29 | -45.44 | -13.88 | 44.32 | -- |
| Bajaj Healthcare Ltd | 6.12bn | 523.16m | 10.24bn | 904.00 | 20.08 | -- | 12.84 | 1.67 | 16.15 | 15.36 | 188.83 | -- | -- | -- | -- | 6,774,850.00 | -- | 7.07 | -- | 13.07 | 46.31 | 37.17 | 8.54 | 8.22 | -- | 2.92 | -- | 5.83 | 14.61 | 5.76 | 399.64 | 11.21 | -12.65 | -- |
| Beta Drugs Ltd | -100.00bn | -100.00bn | 10.68bn | 399.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 15.08 | -- | 21.53 | -- | 40.30 | -- | 12.72 | -- | -- | -- | 0.00 | 22.54 | 31.89 | 28.96 | 37.92 | 19.23 | -- |
| Jagsonpal Pharmaceuticals Ltd | 2.82bn | 409.03m | 11.01bn | 1.40k | 27.10 | -- | 21.87 | 3.91 | 6.07 | 6.07 | 41.76 | -- | -- | -- | -- | 2,012,738.00 | -- | 14.71 | -- | 17.26 | 63.66 | 60.59 | 14.53 | 12.54 | -- | 44.64 | -- | 39.88 | 28.76 | 11.13 | 146.45 | 47.72 | -28.44 | 65.72 |
| Syncom Formulations (India) Ltd | 5.03bn | 689.58m | 11.57bn | 554.00 | 15.78 | -- | 15.58 | 2.30 | 0.78 | 0.78 | 5.58 | -- | -- | -- | -- | 9,072,854.00 | -- | 8.56 | -- | 11.58 | 40.05 | 34.81 | 13.72 | 10.15 | -- | 75.71 | -- | -- | 76.55 | 17.74 | 95.28 | 28.24 | 41.62 | -- |
| Sakar Healthcare Ltd | 2.31bn | 252.21m | 11.66bn | 342.00 | 45.76 | -- | 24.13 | 5.05 | 11.45 | 11.45 | 104.95 | -- | -- | -- | -- | 6,750,901.00 | -- | 4.73 | -- | 5.64 | 52.54 | 45.55 | 10.92 | 9.87 | -- | 3.66 | -- | -- | 15.80 | 16.44 | 49.96 | 12.71 | 19.34 | -- |
| IND Swift Laboratories Ltd | 9.64bn | 2.75bn | 11.90bn | 1.25k | 3.59 | -- | 3.70 | 1.23 | 38.28 | 38.28 | 122.91 | -- | -- | -- | -- | 7,738,014.00 | -- | 8.65 | -- | 10.59 | 51.55 | 40.96 | 28.56 | 14.35 | -- | -3.35 | -- | 0.00 | -56.15 | -6.35 | -40.50 | -- | 41.97 | -- |
| Lincoln Pharmaceuticals Ltd | 6.52bn | 878.34m | 12.40bn | 1.85k | 14.11 | -- | 12.17 | 1.90 | 43.86 | 43.86 | 325.55 | -- | -- | -- | -- | 3,518,272.00 | -- | 13.22 | -- | 15.46 | 53.64 | 50.82 | 13.47 | 14.56 | -- | 77.35 | -- | 3.32 | 7.35 | 10.03 | -11.74 | 9.87 | 20.13 | -- |
| Hester Biosciences Ltd | 3.14bn | 409.47m | 13.12bn | 562.00 | 40.93 | -- | 22.01 | 4.17 | 37.69 | 37.69 | 277.25 | -- | -- | -- | -- | 5,594,555.00 | -- | 5.39 | -- | 6.72 | 73.52 | 64.87 | 13.51 | 11.44 | -- | 9.65 | -- | 23.77 | 2.15 | 11.16 | 45.52 | -1.18 | -22.47 | 1.18 |
| Ngl Fine Chem Ltd | 4.47bn | 353.73m | 14.84bn | 456.00 | 41.95 | -- | 27.88 | 3.32 | 57.26 | 57.26 | 723.35 | -- | -- | -- | -- | 9,799,871.00 | -- | 13.34 | -- | 17.44 | 51.62 | 41.63 | 7.92 | 12.15 | -- | 9.06 | -- | 2.85 | 8.73 | 19.41 | -48.87 | 20.44 | 53.91 | 0.00 |
| Windlas Biotech Ltd | 8.68bn | 667.47m | 15.84bn | 1.35k | 23.89 | -- | 16.19 | 1.82 | 31.46 | 31.46 | 409.16 | -- | -- | -- | -- | 6,450,929.00 | -- | 8.65 | -- | 11.81 | 38.34 | 34.09 | 7.69 | 7.70 | -- | 15.80 | -- | 18.33 | 20.43 | 18.24 | 4.82 | 30.34 | 27.99 | -- |
Data as of Mar 04 2026. Currency figures normalised to Lincoln Pharmaceuticals Ltd's reporting currency: Indian Rupee INR
0.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Maybank Asset Management Sdn. Bhd.as of 31 Jul 2025 | 72.11k | 0.36% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 35.81k | 0.18% |
| Sanlam Investment Management (Pty) Ltd.as of 30 Jan 2026 | 33.87k | 0.17% |
| American Century Investment Management, Inc.as of 05 Feb 2026 | 21.33k | 0.11% |
| Acadian Asset Management LLCas of 30 Sep 2025 | 11.46k | 0.06% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 7.21k | 0.04% |
| DFA Australia Ltd.as of 31 Jan 2026 | 1.87k | 0.01% |
| Motilal Oswal Asset Management Co. Ltd.as of 31 Jan 2026 | 305.00 | 0.00% |
| Bandhan AMC Ltd.as of 31 Jan 2026 | 119.00 | 0.00% |
| State Board of Administration of Florida Retirement Systemas of 30 Sep 2025 | 0.00 | 0.00% |
More ▼
Data from 31 Aug 2025 - 15 Feb 2026Source: FactSet Research Systems Inc.
